This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Ruben Abagyan, PhD
Professor at University of California, San Diego
Speaker

Profile

Ruben Abagyan is a Professor at the Skaggs School of Pharmaceutical Sciences, University of California San Diego, and Molsoft founder. After developing a novel molecular mechanics method for structure-based drug design at the European Institute of Molecular Biology in Heidelberg, Germany, he moved to New York University and Skirball Institute of Biomolecular Medicine as a professor of Biochemistry and Mathematics. In San Diego, he worked as a Director of Computational Chemistry at the Novartis Institute, a Professor at the Scripps Research Institute before joining UCSD. He has published over 340 articles with H-index of 102, and 46,500 citations, and serves as an adviser and reviewer in industry and academia in the US, Europe, and Asia.

Agenda Sessions

  • Exploring Chemical Giga Spaces for New Drug Candidates with Complex Target Profiles

    4:30pm